Crossref journal-article
American Society for Microbiology
Journal of Virology (235)
Abstract

ABSTRACT The membrane-proximal region of the ectodomain of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1) is the target of three of the five broadly neutralizing anti-HIV-1 antibodies thus far isolated. We have determined crystal structures of the antigen-binding fragment for one of these antibodies, 2F5, in complex with 7-mer, 11-mer, and 17-mer peptides of the gp41 membrane-proximal region, at 2.0-, 2.1-, and 2.2-Å resolutions, respectively. The structures reveal an extended gp41 conformation, which stretches over 30 Å in length. Contacts are made with five complementarity-determining regions of the antibody as well as with nonpolymorphic regions. Only one exclusive charged face of the gp41 epitope is bound by 2F5, while the nonbound face, which is hydrophobic, may be hidden due to occlusion by other portions of the ectodomain. The structures reveal that the 2F5 antibody is uniquely built to bind to an epitope that is proximal to a membrane surface and in a manner mostly unaffected by large-scale steric hindrance. Biochemical studies with proteoliposomes confirm the importance of lipid membrane and hydrophobic context in the binding of 2F5 as well as in the binding of 4E10, another broadly neutralizing antibody that recognizes the membrane-proximal region of gp41. Based on these structural and biochemical results, immunization strategies for eliciting 2F5- and 4E10-like broadly neutralizing anti-HIV-1 antibodies are proposed.

Bibliography

Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004). Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope. Journal of Virology, 78(19), 10724–10737.

Authors 7
  1. Gilad Ofek (first)
  2. Min Tang (additional)
  3. Anna Sambor (additional)
  4. Hermann Katinger (additional)
  5. John R. Mascola (additional)
  6. Richard Wyatt (additional)
  7. Peter D. Kwong (additional)
References 68 Referenced 403
  1. 10.1074/jbc.M106229200
  2. 10.1016/S0022-2836(03)00611-9
  3. 10.1021/bi026261y
  4. 10.1107/S0907444998003254
  5. 10.2174/0929866013409201
  6. 10.1089/aid.1994.10.359
  7. 10.1126/science.1083182
  8. 10.1016/S0092-8674(00)80205-6
  9. 10.1016/S0092-8674(00)81430-0
  10. 10.1016/S0264-410X(00)00267-X
  11. 10.1107/S0907444994003112
  12. 10.1016/S0022-2836(02)01222-6
  13. 10.1073/pnas.91.8.3348
  14. 10.1107/S0021889883010985
  15. 10.1073/pnas.93.1.7
  16. 10.1128/JVI.78.5.2627-2631.2004
  17. 10.1099/0022-1317-77-9-2001
  18. 10.1093/nar/26.7.1718
  19. 10.1128/JVI.76.23.12123-12134.2002
  20. 10.1038/nsb0498-276
  21. 10.1128/JVI.76.7.3511-3521.2002
  22. 10.1016/S0264-410X(01)00441-8
  23. 10.1073/pnas.0308527100
  24. 10.1107/S0108767390010224
  25. Kuiken C. L. B. Foley B. Hahn B. Korber P. A. Marx F. McCutchan J. W. Mellors and S. Wolinksy. 2001. HIV sequence compendium. Theoretical Biology and Biophysics Group Los Alamos National Laboratory Los Alamos N.Mex. (10.2172/1184349)
  26. 10.1089/aid.1998.14.1115
  27. 10.1002/(SICI)1097-0290(20000105)67:1<97::AID-BIT11>3.0.CO;2-2
  28. 10.1038/nature01188
  29. 10.1107/S0021889898009686
  30. 10.1128/JVI.77.19.10557-10565.2003
  31. 10.1107/S0021889892009944
  32. 10.1016/S0264-410X(99)00125-5
  33. 10.1016/S0196-9781(00)00179-0
  34. 10.1128/JVI.76.10.4810-4821.2002
  35. 10.1006/jmbi.1994.1334
  36. 10.1021/bi026952u
  37. 10.1006/jsbi.1999.4094
  38. Merritt, E. A., and D. J. Bacon. 1997. Macromolecular crystallography. Methods Enzymol. 277:505-524. / Methods Enzymol. 277 (1997)
  39. 10.1128/JVI.73.7.6089-6092.1999
  40. 10.1128/jvi.68.6.4031-4034.1994
  41. 10.1128/jvi.67.11.6642-6647.1993
  42. 10.1002/prot.340110407
  43. 10.1016/S0076-6879(97)76066-X
  44. Pai E. F. M. H. Klein P. Chong and A. Pedyczak. April 2000. Fab′-epitope complex from the HIV-1 cross-neutralizing monoclonal antibody 2F5. World Intellectual Property Organization patent WO-00/61618.
  45. 10.1128/JVI.77.10.5889-5901.2003
  46. 10.1128/JVI.75.22.10906-10911.2001
  47. 10.1097/00002030-199506000-00001
  48. 10.1097/00002030-199606000-00003
  49. 10.1089/aid.1994.10.1651
  50. 10.1073/pnas.0630530100
  51. 10.1128/jvi.68.8.4821-4828.1994
  52. 10.1002/(SICI)1097-0320(19971201)29:4<328::AID-CYTO10>3.0.CO;2-W
  53. 10.1128/JVI.73.3.2469-2480.1999
  54. 10.1126/science.1061692
  55. 10.1016/S0042-6822(95)80094-8
  56. 10.1021/bi010640u
  57. 10.1089/08892220152741450
  58. 10.1016/0022-0248(91)90896-D
  59. 10.1034/j.1399-3011.2002.02988.x
  60. 10.1128/jvi.69.11.6609-6617.1995
  61. 10.1128/jvi.70.2.1100-1108.1996
  62. 10.1038/nature01470
  63. 10.1038/316069a0
  64. 10.1038/387426a0
  65. 10.3109/08820130009105143
  66. 10.1128/JVI.78.11.5642-5650.2004
  67. 10.1128/JVI.78.6.3155-3161.2004
  68. 10.1128/JVI.75.22.10892-10905.2001
Dates
Type When
Created 20 years, 11 months ago (Sept. 14, 2004, 4:48 p.m.)
Deposited 3 years, 5 months ago (March 5, 2022, 3:42 a.m.)
Indexed 1 month, 4 weeks ago (July 3, 2025, 2:03 p.m.)
Issued 20 years, 11 months ago (Oct. 1, 2004)
Published 20 years, 11 months ago (Oct. 1, 2004)
Published Print 20 years, 11 months ago (Oct. 1, 2004)
Funders 0

None

@article{Ofek_2004, title={Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope}, volume={78}, ISSN={1098-5514}, url={http://dx.doi.org/10.1128/jvi.78.19.10724-10737.2004}, DOI={10.1128/jvi.78.19.10724-10737.2004}, number={19}, journal={Journal of Virology}, publisher={American Society for Microbiology}, author={Ofek, Gilad and Tang, Min and Sambor, Anna and Katinger, Hermann and Mascola, John R. and Wyatt, Richard and Kwong, Peter D.}, year={2004}, month=oct, pages={10724–10737} }